• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

FHIT Suppresses Prostaglandin E_2 in the Carcinogenic Activity by Inflammation in Colorectal Cancer.

Research Project

Project/Area Number 15390379
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field General surgery
Research InstitutionKYUSHU UNIVERSITY

Principal Investigator

KOSHI Mimori  Kyushu University, Medical institute of Bioregulation, Research Associate, 生体防御医学研究所, 助手 (50322748)

Co-Investigator(Kenkyū-buntansha) MORI Masaki  Kyushu University, Medical institute of Bioregulation, Professor, 生体防御医学研究所, 教授 (70190999)
INOUE Hiroshi  Kyushu University, Medical Institute of Bioregulation, Associate Professor, 生体防御医学研究所, 助教授 (90203249)
白石 猛  九州大学, 大学病院, 助手 (30315139)
Project Period (FY) 2003 – 2004
Project Status Completed (Fiscal Year 2004)
Budget Amount *help
¥14,700,000 (Direct Cost: ¥14,700,000)
Fiscal Year 2004: ¥6,700,000 (Direct Cost: ¥6,700,000)
Fiscal Year 2003: ¥8,000,000 (Direct Cost: ¥8,000,000)
KeywordsFHIT / Colorectal cancer / PGE_2 / COX-2 / inflammation / RNAi / Ad-FHIT / c-Src / PG E2 / adenoviral FHIT / Apoptosis / clorectal cancer / carcinogens / Fhit / Cox2 / PGE2 / Adenovirus-Fhit / Microarray / 蛋白カスケード / E2F
Research Abstract

The FHIT gene is considered to be susceptible to environmental carcinogens, such as tobacco and alcohols. The inflammation in the cmicrocircumstances were defined by arachidonic cascade which is mediated through cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2) may influence the malignant phenotype of colorectal cancer (CRC) by acting as mediators in carcinogen affected epithelial tissues. In the present study, immunohistochemical analysis of 62 CRCs showed that a subset of CRC cases with COX-2 overexpression but no FHIT expression exhibited more advanced clinicopathological features (depth of tumor invasion, p < 0.007 ; Dukes stage, p < 0.007), compared to cases with undetectable COX-2 but positive FHIT expression. In vitro experiments using induced FHIT expressing cells showed a diminished COX-2 expression by western blotting compared with control cells. Moreover, after stimulation by COX-2 inducers (lipopolysaccharide, phorbol 12-myristate 13-acetate or interleukin 1 beta), PGE2 … More production and cell proliferation were repressed (0.75-fold and 0.87-fold) in FHIT expressing cells compared to control cells, as determined by ELISA and MTT assays, respectively. On the other hand, we established FHIT siRNA clones and repressed FHIT expression in colorectal cancer cell line, CCK81. As a result, PGE2 production by ELISA and the cellular proliferation by MTT assay was diminished in the FHIT inhibited cell by RNAi comparing with the control FHIT. In conclusion, loss of FHIT expression with overexpression of COX-2 in CRC may predict a higher malignant potential. Conversely, FHIT protein induction repressed cell proliferation by inhibiting prostaglandin E2 production in colorectal cancer.
Moreover, the current comprehensive gene analysis after adenoviral-FHIT (Ad-FHIT) treatment is therefore considered to shed some light on the following two points. One is to clarify the mechanism of apoptotic activity by Ad-FHIT and the other is to identify the candidate cancer associated targets affected by Ad-FHIT treatment. Those molecules may consider to be a fine target under the inflammation mediated carcinogenic activity in CRC cases. Less

Report

(3 results)
  • 2004 Annual Research Report   Final Research Report Summary
  • 2003 Annual Research Report
  • Research Products

    (25 results)

All 2005 2004 Other

All Journal Article (18 results) Book (1 results) Publications (6 results)

  • [Journal Article] Clinical significance of the expression of enhancer of zeste homolog 2 in colorectal cancer cases.2005

    • Author(s)
      Mimori K
    • Journal Title

      Eur J Surg Oncol 31

      Pages: 376-380

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Somatic mutations of epidermal growth factor receptor in colorectal carcinoma.2005

    • Author(s)
      Nagahara H, Mimori K
    • Journal Title

      CLin Cancer Res 11

      Pages: 1368-1371

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Differential Roles of E-Type Cyclins During Transformation of Muripe E2F-1-Deficient Cells.2005

    • Author(s)
      Ishii H, Mimori K
    • Journal Title

      DNA Cell Biol 24

      Pages: 173-179

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Clinical significance of the expression of enhancer of zeste homolog 2 in colorectal cancer cases.2005

    • Author(s)
      Mimori K, et al.
    • Journal Title

      Eur J Surg Oncol 31

      Pages: 376-380

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Somatic mutations of epidermal growth factor receptor in colorectal carcinoma.2005

    • Author(s)
      Nagahara H, Mimori K, et al.
    • Journal Title

      Clin Cancer Res 11

      Pages: 1368-1371

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Differential Roles of E-Type Cyclins During Transformation of Murine E2F-1-Deficient Cells.2005

    • Author(s)
      Ishii H, Mimori K, et al.
    • Journal Title

      DNA Cell Biol 24

      Pages: 173-179

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer.2004

    • Author(s)
      Mimori K
    • Journal Title

      Ann Oncol 15

      Pages: 236-241

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Coexpression of MMP-7 and EGF receptor in colorectal cancer ; an EGF receptor tyrosine kinase inhibitor is effective against MMP-7 expressing cancer cells.2004

    • Author(s)
      Mimori K
    • Journal Title

      Clin Cancer Res 10

      Pages: 8243-8249

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Effect of exogeneous E2F-1 on the expression of common chromosomeragile site genes, FHIT and WWOX.2004

    • Author(s)
      Ishii H, Mimori K
    • Journal Title

      Biophys Biochem Res Commun 316

      Pages: 1088-1093

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer.2004

    • Author(s)
      Mimori K, Tanaka Y, Yoshinaga K, et al.
    • Journal Title

      Ann Oncol 15

      Pages: 236-241

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Coexpression of MMP-7 and EGF receptor in colorectal cancer ; an EGF receptor tyrosine kinase inhibitor2004

    • Author(s)
      Mimori K, Yamashita K, Ohta M, et al.
    • Journal Title

      Clin Cancer Res 10

      Pages: 8243-8249

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Effect of exogenous E2F-1 on the xpression of common chromosome fragile site genes, FHIT and WWOX.2004

    • Author(s)
      Ishii H, Mimori K, Vecchione A, et al.
    • Journal Title

      Biochem Biophys Res Commun 316

      Pages: 1088-1093

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Coexpression of MMP-7 and EGF receptor in colorectal cancer, an EGF receptor tyrosine kinase inhibitor is effective against MMP-7 expressing cancer cells.2004

    • Author(s)
      Mimori K
    • Journal Title

      Clin Cancer Res 10

      Pages: 8243-8249

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Thymidine phosphorylase activity predicts 5'-dFUR sensitivity in colorectal cancer : candidate sensitivity genes identified by analysis microarray2004

    • Author(s)
      Mimori K
    • Journal Title

      Onocl Rep 12

      Pages: 19-23

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Effect of exogenous E2F-1 on the expression of common chromosome fragile site genes, FHIT and WWOX.2004

    • Author(s)
      Ishii H
    • Journal Title

      Biophys Biochem Res Commun 316

      Pages: 1088-1093

    • Related Report
      2004 Annual Research Report
  • [Journal Article] N-cardherin is regulated by activin a and associated with tumor aggressiveness in esophageal carcinoma.2004

    • Author(s)
      Yoshinaga K
    • Journal Title

      Clin Cancer Res 10

      Pages: 5702-5707

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Clinical significance of the expression of enhancer of zeste homolog 2 in colorectal cancer cases.

    • Author(s)
      Mimori K
    • Journal Title

      Eur J Surg Oncol (In press)

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Identification of molecular markers foe metastasis-related genes in primary breast cancer cells.

    • Author(s)
      Mimori K
    • Journal Title

      Clin Exp Metastasis (In press)

    • Related Report
      2004 Annual Research Report
  • [Book] 乳癌診断のコツと落とし穴2004

    • Author(s)
      三森功士
    • Publisher
      中山書店
    • Related Report
      2004 Annual Research Report
  • [Publications] Mimori K, Shiraishi T, et al.: "MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway."Oncogene. 22. 3463-3471 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Mimori K, Inoue H, et al.: "Microsatellite instability is often observed in esophageal carcinoma patients with allelic loss in the FHIT/FRA3B locus."Oncology. 64. 275-279 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Yamashita K, Mimori K: "A tumor-suppressive role for trypsin in human cancer progression."Cancer Res. 63. 6575-6578 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Mimori K, Tanaka Y, et al.: "Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer."Ann Oncol. 15. 236-241 (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Mimori K, Ueo H, et al.: "Thymidine phosphorylase activity predicts 5'-dFUR sensitivity in colorectal cancer : candidate sensitivity genes identified by analysis microarray"Oncology Report. In press. (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Ishii H, Mimori K.et al.: "Effect of exogeneous E2F-1 on the expression of common chromosome fragile site genes, FHIT and WWOX."BBRC. 2004. (2004)

    • Related Report
      2003 Annual Research Report

URL: 

Published: 2003-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi